Wellington Management Group
TNGX icon

Wellington Management Group’s Tango Therapeutics TNGX Stock Holding History

Wellington Management Group’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.29M Buy
297,106
+7,926
+3% +$196K ﹤0.01% 1310
2026
Q1 		$6.05M Buy
289,180
+55,323
+24% +$770K ﹤0.01% 1369
2025
Q4 		$2.07M Sell
233,857
-19,431
-8% -$167K ﹤0.01% 1591
2025
Q3 		$2.13M Buy
+253,288
New +$1.71M ﹤0.01% 1618
2025
Q1 		– Sell
-138,247
Closed -$427K – 2052
2024
Q4 		$427K Sell
138,247
-4,960
-3% -$23K ﹤0.01% 1847
2024
Q3 		$1.1M Sell
143,207
-6,570
-4% -$62.7K ﹤0.01% 1690
2024
Q2 		$1.29M Buy
149,777
+8,782
+6% +$67.9K ﹤0.01% 1612
2024
Q1 		$1.12M Sell
140,995
-29,233
-17% -$313K ﹤0.01% 1662
2023
Q4 		$1.69M Buy
170,228
+89,481
+111% +$777K ﹤0.01% 1521
2023
Q3 		$909K Buy
+80,747
New +$492K ﹤0.01% 1625

Other funds holding TNGX

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Wellington Management Group's TNGX Position: Q2 2026 in Review

Wellington Management Group increased its Tango Therapeutics (TNGX) stake by 2.7% in Q2 2026, buying an estimated $196K and bringing the position to 297,106 shares worth $9.29M. The position accounts for ﹤0.01% of the portfolio, ranked #1310.

Wellington Management Group first reported a position in TNGX in Q3 2023 and has held it in 10 quarters since. 249 funds tracked by Wall St. Rank hold TNGX as of Q2 2026.

  • Wellington Management Group held 297,106 shares of Tango Therapeutics worth $9.29M as of Q2 2026.
  • Wellington Management Group bought 7,926 Tango Therapeutics shares in Q2 2026, an estimated $196K.
  • Tango Therapeutics made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1310 holding.
  • Wellington Management Group first reported a position in Tango Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 249 funds tracked by Wall St. Rank held Tango Therapeutics as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.